先天性心脏病接受心脏手术儿童的静脉血栓栓塞新发、复发及抗血栓治疗使用风险:全球多中心真实世界数据分析
本研究利用TriNetX全球电子健康记录真实世界数据平台,纳入24879例18岁以下因先天性心脏病接受心脏手术的儿童。其中1475例(5.9%)在术后1年内发生急性静脉血栓栓塞,1年复发率为25%(372例)。作者认为需前瞻性多中心研究以识别相关因素。
要点
- 24879例先心病心脏手术儿童中1475例(5.9%)术后1年内发生急性静脉血栓栓塞。
- 下肢深静脉血栓最常见(999例,67.7%),Glenn手术最常见(432例,29.3%)。
- 1年血栓栓塞复发率为25%(372例),其中下肢深静脉血栓305例(81.9%)。
核心结论
- 约6%接受心脏手术的儿童在1年内发生静脉血栓栓塞,1年血栓栓塞复发风险为25%。
- 作者认为需前瞻性多中心研究以识别与静脉血栓栓塞发生和复发相关的因素,为未来预防新发和复发静脉血栓栓塞的干预试验提供依据。
研究设计与样本
- 研究查询TriNetX全球电子健康记录衍生真实世界数据研究平台,纳入18岁以下因先天性心脏病接受心脏手术且术后1年内诊断静脉血栓栓塞的患者。
- 对患者和静脉血栓栓塞特征、抗血栓治疗及复发性血栓栓塞数据进行描述性分析。
主要发现
- 24879例儿童中1475例(5.9%)在术后1年内发生急性静脉血栓栓塞。
- 下肢深静脉血栓最常见(999例,67.7%),Glenn手术为最常见手术类型(432例,29.3%)。
- 急性期(诊断后<7天)使用普通肝素1022例(69.3%),亚急性期(诊断后≥7天至3个月)使用普通肝素895例(60.7%)。
- 1年复发性血栓栓塞发生率高(372例,25%),其中大多数为下肢深静脉血栓(305例,81.9%)。
局限性
- 作者指出需前瞻性多中心研究以识别与静脉血栓栓塞发生和复发相关的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Data on the characteristics and antithrombotic treatments of venous thromboembolism (VTE) among children with congenital heart disease undergoing cardiac surgery are limited. OBJECTIVES: We aimed to evaluate the features and rates of recurrent thromboembolism in real-world experience using a global multicenter dataset. METHODS: We queried the TriNetX global electronic health record-derived real-world data research platform for patients <18 years of age who underwent cardiac surgery for congenital heart disease with a diagnosis of VTE within 1 year of surgery. Data on patient and VTE characteristics, antithrombotic therapies, and recurrent thromboembolism were descriptively analyzed. RESULTS: Of 24 879 children, 1475 (5.9%) developed an acute incident VTE within 1 year of surgery. Lower extremity deep venous thrombosis (n = 999, 67.7%) was the most common VTE type, and the Glenn procedure was the most common surgery type (n = 432, 29.3%). Unfractionated heparin was utilized for acute (<7 days after diagnosis) and subacute (≥7 days to 3 months after diagnosis) VTE treatment in 1022 (69.3%) and 895 (60.7%) patients, respectively. The 1-year rate of recurrent thromboembolism was high (n = 372, 25%), most of which were lower extremity deep venous thrombosis (n = 305, 81.9%). CONCLUSION: Approximately 6% of children undergoing cardiac surgery develop VTE within 1 year. The 1-year risk of thromboembolism recurrence is 25%. Prospective multicenter studies are essential to identify factors associated with the occurrence and recurrence of VTE in children undergoing cardiac surgery. This research will provide valuable insights for future interventional trials focused on preventing incident and recurrent VTE in this vulnerable population.
引用
- Kiskaddon AL, Do NL, Amankwah EK, et al. Risks of incident venous thromboembolism, recurrent thromboembolism, and use of antithrombotic therapies among children with congenital heart disease undergoing cardiac surgery: a global multicenter analysis of real-world data. J Thromb Haemost. 2025. PMID: 40090621. doi:10.1016/j.jtha.2025.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。